Articles

"Yinghua Chenrui" Zhou Zhen: Solving Biomaterial Industry Bottlenecks with Unique Modification Technology and Processing Techniques | Linear Capital Portfolio Interview Series

"Yinghua Chenrui" Zhou Zhen: Solving Biomaterial Industry Bottlenecks with Unique Modification Technology and Processing Techniques | Linear Capital Portfolio Interview Series

In late December 2023, bio-based materials high-performance modification and application innovation company **Yinghua Chenrui** announced the completion of a tens of millions of RMB angel funding round.

VBData Exclusive | Dalton Venture: The Next Phase of Opportunities in Healthcare — "Technology + Safety" Is the Unavoidable Theme

VBData Exclusive | Dalton Venture: The Next Phase of Opportunities in Healthcare — "Technology + Safety" Is the Unavoidable Theme

In a turbulent environment, most investment firms have chosen to play it safe, pulling back on deal activity. Yet in 2023 — widely called a funding winter — Dalton Venture actually picked up its investment pace. How does the firm see 2024 shaping up? At the start of the new year, Sun Qi, founding and managing partner of Dalton Venture, sat down with VBData to share his outlook on healthcare trends for 2024 and his advice for founders.